Tom Morley, PhD

Tom Morley is the Executive Director of the RPD team at Aktis Oncology. Prior to his time at Aktis he spent eight years at Invicro, four years overseeing the GMP manufacturing lab as the Associate Director of Radiochemistry, contributing to over 40 INDs, and four years at Invicro Boston as the Director of Translation Chemistry, where he was responsible for the External Manufacturing team. Tom has also worked as Senior Scientist at GE Healthcare developing their 18F-CD8 asset, and at TRIUMF in Vancouver developing Tc-99m via cyclotron in what would become ARTMS. Tom has a B.A., M.Sci and Ph.D in organic chemistry from the University of Cambridge and a postdoc in biochemistry from the University of British Columbia. When not at Aktis Tom runs marathons, triathlons, and enjoys spending time on trips with his family.